EOJOAM
ABMD

E. Ohman J:or Asset Management’s Abiomed Inc ABMD Stock Holding History

E. Ohman J:or Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,000
Closed -$491K – 452
2022
Q3 		$491K Sell
2,000
-500
-20% -$135K 0.02% 340
2022
Q2 		$619K Hold
2,500
– – 0.03% 320
2022
Q1 		$828K Hold
2,500
– – 0.03% 305
2021
Q4 		$898K Buy
+2,500
New +$845K 0.03% 323
2019
Q4 		– Sell
-4,727
Closed -$841K – 485
2019
Q3 		$841K Buy
4,727
+1,200
+34% +$259K 0.05% 190
2019
Q2 		$919K Buy
3,527
+2,327
+194% +$617K 0.06% 169
2019
Q1 		$343K Buy
+1,200
New +$399K 0.02% 298

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

E. Ohman J:or Asset Management's ABMD Position: Q4 2022 in Review

E. Ohman J:or Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,000 shares — an estimated $491K sold.

E. Ohman J:or Asset Management first reported a position in ABMD in Q1 2019 and held it in 7 quarters. The position peaked at $919K in Q2 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • E. Ohman J:or Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • E. Ohman J:or Asset Management sold 2,000 Abiomed Inc shares in Q4 2022, an estimated $491K.
  • E. Ohman J:or Asset Management first reported a position in Abiomed Inc in Q1 2019 and held it in 7 quarters.
  • E. Ohman J:or Asset Management's Abiomed Inc position peaked at $919K in Q2 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on E. Ohman J:or Asset Management's 13F filing for Q4 2022, filed 5 Apr 2024.